Clinical trial / 2005
Daily supplementation with 114 mg of isolated soy isoflavones for 3 months did not affect vaginal dryness or endometrial measures in postmenopausal women.
In a double-blind, randomized, placebo-controlled crossover trial, 64 postmenopausal women with a history of breast cancer took 114 mg of isolated isoflavonoids or placebo daily for 3 months, separated by a 2-month washout period. Isolated isoflavones did not relieve vaginal dryness. Vaginal maturation index values remained unchanged during isoflavone treatment but decreased during placebo. No changes were observed in any endometrial variables, including thickness, histology, estrogen and progesterone receptors, or Ki-67 expression.
- Study type
- Double-blind, randomized, placebo-controlled crossover trial
- Who was studied
- 64 postmenopausal women with a history of breast cancer
- What was measured
- Vaginal dryness, vaginal maturation index, endometrial thickness, histology, and endometrial ER, PR, and Ki-67 expression
THE PAPER
Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women.
Nikander E, Rutanen EM, Nieminen P, Wahlström T, Ylikorkala O, Tiitinen A. Fertil Steril, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.